摘要：SummaryTNFα is implicated in chronic lymphocytic leukemia (CLL) immunosuppression and disease progression. TNFα is constitutively produced by CLL B cells and is a negative regulator of bone marrow (BM) myelopoiesis. Here, we show that co-culture of CLL B cells with purified normal human hematopoietic stem and progenitor cells (HSPCs) directly altered protein levels of the myeloid and erythroid cell fate determinants PU.1 and GATA-2 at the single-cell level within transitional HSPC subsets, mimickingex vivoexpression patterns. Physical separation of CLL cells from control HSPCs or neutralizing TNFα abrogated upregulation of PU.1, yet restoration of GATA-2 required TNFα neutralization, suggesting both cell contact and soluble-factor-mediated regulation. We further show that CLL patient BM myeloid progenitors are diminished in frequency and function, an effect recapitulated by chronic exposure of control HSPCs to low-dose TNFα. These findings implicate CLL B-cell-derived TNFα in impaired BM myelopoiesis.Graphical abstractDisplay OmittedHighlights•CLL patient BM HSPCs exhibit aberrant molecular and functional characteristics•CLL B-cell-derived TNFα upregulates PU.1 and GATA-2 in BM HSPCs•The effects of CLL B-cell-derived TNFα are reversible upon TNFα neutralization•Chronic TNFα exposurein vitrorecapitulatesex vivoHSPC functional deficienciesMolecular Biology; Immunology; Stem Cells Research
